Category: Boston ScientificSyndicate content

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

BSX wins CE Mark, FDA approval for spinal cord stims | Regulatory news for the week of October 27, 2014

October 28, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark, FDA nod for spinal surgical leads; ReFlow has new Wingman35 in U.S. market; Auditors: FDA needs to boost cybersecurity; Life Spine creates Centric Medical ankle & foot unit

Boston Scientific wins CE Mark, FDA nod for spinal surgical leads

October 21, 2014 by Brad Perriello

Former BSX engineer indicted on charges of stealing balloon cath trade secrets from the company | Medtech legal news for the week of October 27, 2014

October 27, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Ex-Boston Scientific engineer accused of stealing balloon catheter secrets; Jury clears DePuy in 1st Pinnacle bellwether trial; U.S. Patent Office denies Medtronic request in Endotach stent case; Jury deliberations begin in first trial over DePuy's Pinnacle hips; Johnson & Johnson's DePuy wins first trial over Pinnacle hips

Ex-Boston Scientific engineer accused of stealing balloon catheter secrets

October 21, 2014 by Brad Perriello

Medtech's betting on the GOP in midterm elections

October 24, 2014 by Brian Johnson

A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.

Medtech's betting on the GOP in midterm elections

The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.

Boston Scientific, Bard CEOs cool on consolidation

October 23, 2014 by Brad Perriello

The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.

Boston Scientific, Bard CEOs cool on consolidation

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific's Q3 profits rise on heart device sales

October 22, 2014 by MassDevice

Sales of its cardiac rhythm management devices help boost Boston Scientific above expectations for the 3rd quarter.

Boston Scientific's Q3 profits rise on heart device sales

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific wins CE Mark, FDA nod for spinal surgical leads

October 21, 2014 by Brad Perriello

Boston Scientific says its CoverEdge 32 and CoverEdge X 32 surgical leads won CE Mark approval in the European Union and pre-market approval from the FDA for use with its Precision Spectra spinal cord stimulator.

Boston Scientific wins CE Mark, FDA nod for spinal surgical leads

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp